scholarly journals Transient Serotonin Toxicity Evoked by Combination of Electroconvulsive Therapy and Fluoxetine

2014 ◽  
Vol 2014 ◽  
pp. 1-2 ◽  
Author(s):  
René Klysner ◽  
Birgitte Bjerg Bendsen ◽  
Maja Soon Hansen

The serotonin syndrome has been described only in rare instances for electroconvulsive therapy combined with an antidepressant medication. We describe a case of serotonin toxicity induced by electroconvulsive therapy in combination with fluoxetine.

2009 ◽  
Vol 15 (3) ◽  
pp. 181-191 ◽  
Author(s):  
Niraj Ahuja ◽  
Andrew J. Cole

SummaryPresence of fever in psychiatric patients may signify a number of potentially fatal conditions. Several of these are related to treatments (e.g. neuroleptic malignant syndrome with antipsychotics, serotonin syndrome with serotonergic antidepressants, and malignant hyperpyrexia with anaesthesia used for administration of electroconvulsive therapy) or exacerbated by them (e.g. malignant catatonia with antipsychotics). New classes of drug treatment may be changing the epidemiology of these disorders. We suggest that an initial diagnosis of hyperthermia syndrome is clinically useful as there are some important commonalities in treatment. We outline a systematic approach to identify a particular subtype of hyperthermia syndrome and the indications for more specific treatments where available.


Author(s):  
Kevin T. Gobeske ◽  
Eelco F. M. Wijdicks

Serotonin syndrome affects the central nervous system, the autonomic nervous system, and the neuromuscular system and can have acute and potentially life-threatening manifestations. By definition, serotonin syndrome is associated with changes in serotonin exposure and thus might be described more accurately as serotonergic excess or serotonin toxicity. The central nervous system effects of serotonin involve regulation of attention, arousal, mood, learning, appetite, and temperature.


2015 ◽  
Vol 1 (4) ◽  
pp. 174-178
Author(s):  
Asha Naik ◽  
Cristobal Rincon-Aznar

Abstract We report a case of delayed recovery from general anesthesia following a routine parathyroidectomy. Our objectives are to describe the process of establishing a differential diagnosis and subsequent management of a patient presenting with atypical neurological signs from an unknown etiology and to increase awareness about the potential for serotonin syndrome and neurotoxicity due to known interactions between methylene blue and selective serotoninnoradrenaline re-uptake inhibitors. ICU management of Serotonin Toxicity is briefly described.


2004 ◽  
Vol 24 (4) ◽  
pp. 400-403 ◽  
Author(s):  
Walter W. van den Broek ◽  
Ariejan de Lely ◽  
Paul G.H. Mulder ◽  
Tom K. Birkenh??ger ◽  
Jan A. Bruijn

Cureus ◽  
2021 ◽  
Author(s):  
Ariel Ruiz de Villa ◽  
Tyler Jones ◽  
Amina Lleshi ◽  
Monica Macahuachi ◽  
Katie Lamar ◽  
...  

2016 ◽  
Vol 50 (01) ◽  
pp. 41-42
Author(s):  
Michael Deuschle ◽  
Andreas Böhringer ◽  
Andreas Meyer-Lindenberg ◽  
Alexander Sartorius

2006 ◽  
Vol 7 (2) ◽  
pp. 82-90 ◽  
Author(s):  
Thomas C. Baghai ◽  
Alain Marcuse ◽  
Melanie Brosch ◽  
Cornelius Schüle ◽  
Daniela Eser ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document